VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 3 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,254,000 | +57.2% | 140,000 | +7.7% | 1.25% | +29.5% |
| Q1 2018 | $2,070,000 | -0.4% | 130,000 | +30.0% | 0.97% | +25.3% |
| Q4 2017 | $2,078,000 | -17.1% | 100,000 | -42.9% | 0.77% | -9.6% |
| Q3 2017 | $2,508,000 | -40.8% | 175,000 | -28.6% | 0.85% | -45.0% |
| Q2 2017 | $4,239,000 | +92.2% | 245,000 | +22.5% | 1.55% | +51.1% |
| Q1 2017 | $2,206,000 | – | 200,000 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |